Novartis posts first-quarter sales, profit beat as COVID-19 spurs prescriptions

Swiss drugmaker Novartis reported rising first-quarter sales and profit that beat analyst expectations and confirmed its 2020 targets as the coronavirus pandemic prompted patients to stock up on their prescriptions in advance.